Closed

hire a researcher to join the Cellular Immunotherapy and Gene Therapy Group

Barcelona Ref. 2026/088

Call for a hire a researcher to join the Cellular Immunotherapy and Gene Therapy Group. Deadline: June 25, 2026, 3:00 pm

About the Group

The Cellular Immunotherapy and Gene Therapy Group (GITG) focuses on the study of genetically modified T cells that express chimeric antigen receptors (CARs) and their clinical application in patients with hematologic malignancies

The GITG group at IR-Sant Pau is a consolidated and pioneering team in the development and production of CART cells for treating patients with hematologic cancers. The group developed a clinical trial with HSP-CAR30 cells for patients with Hodgkin lymphoma—the first of its kind in Europe—and recently initiated a second clinical trial in patients with refractory B-cell lymphomas using memory CART19 cells, a unique project in Europe. The HSP-CAR30 and HSP-CAR19M products are entirely manufactured at Sant Pau by the GITG group in compliance with Good Manufacturing Practice (GMP) standards.

The current research lines focus on:

  • Evaluating the antitumor efficacy of memory T cell subsets.
  • Studying genetically modified stem memory T cells with CAR.
  • Developing innovative 4th generation CARs targeting antigens expressed in hematologic cancers.
  • Conducting CART cell immunotherapy clinical trials in patients with lymphoid malignancies.

Essential requirements

  • PhD in Health Sciences or similar
  • Experience in cell culture, molecular biology, blood sample analysis, flow cytometry.
  • Experience with animal models (rodents) and certified to perform in vivo studies.
  • High level of collaboration and communication skills.
  • High motivation and interest.
  • Intermediate level in office software (Excel, Word, PowerPoint, etc). Skills will be valued
  • Previous experience in immunology and/or hemato-oncology.
  • Experience in CART cell therapy.
  • English language skills.
  • Oral and written proficiency in both official languages of Catalonia, or a commitment to acquire it within one year.

Functions

  • Develop research projects to evaluate the antitumor efficacy of 4th generation CART in hematologic cancer models.
  • Design and conduct in vitro and in vivo experiments.
  • Data analysis and interpretation
  • Present findings at national/international meetings
  • Management of patient biological samples for studies related to the antitumor effects of treatment.
  • Coordination of biological studies across institutional platforms.

Offered

  • Permanent contract linked to the CAR-T cell therapy project.
  • This position is funded under the Resolution of the Carlos III Health Institute (ISCIII) awarding grants for Independent Clinical Research Projects within the 2025 Strategic Action in Health – Strategic Health Research Lines.This contract is funded by the Carlos III Health Institute (ISCIII), grant reference ICI25/0065, and co-funded by the European Union (ERDF).
  • Annual working time: 1,627.50 hours (37.5 hours/week).
  • Salary according to ISCIII salary scales.
  • Research Group: Cellular Immunotherapy and Gene Therapy Group (Hematology).

Documentation and deadline for submission

Interested parties should preferably deliver the documentation (1) in PDF, by e-mail to the Management of the Santa Creu i Sant Pau Hospital Research Institute Foundation, address ir_seleccio@santpau.cat , indicating the reference 2026/088:

(1) Application letter and updated Curriculum Vitae and signed Data Processing Authorization**

At the request of the Santa Creu i Sant Pau Hospital Research Institute Foundation, the candidates must present the documentation accrediting the merits mentioned in the curriculum vitae. Applications will be resolved within a maximum period of one month from the end of the deadline for submission of documentation. At the end of this period, without having been notified of an express resolution, the interested parties will be entitled to understand that their applications have been rejected. Santa Creu i Sant Pau Hospital Research Institute Foundation may declare this call for applications closed if, according to its criteria, candidates does not meet the conditions that the Institution considers necessary to fill the position. The interpretation of the requirements and their enforceability to the candidates will be exclusive to the Santa Creu i Sant Pau Hospital Research Institute Foundation.

**És imprescindible adjuntar l'autorització de tractament de dades degudament signada (document adjunt al final de la convocatòria) **

The deadline for submitting applications will end on June 25th 2026, at 3:00 p.m.

Barcelona, Tel: 93 291 90 50, NIF: G-60136934,

Apply to this offer

Accepted File Extensions: PDF, DOC, DOCX, ODT, TXT (max 10 MB)
Accepted File Extensions: PDF, DOC, DOCX, ODT, TXT (max 10 MB)
Text to Identify Refresh CAPTCHA